E-LIB Suche - Ergebnisse für: Michael Nelson, D

1

Differences in neutralizing antibody sensitivities and enve..:

Wieczorek, Lindsay ; Chang, David ; Sanders-Buell, Eric...
Virology Journal. 21 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Impact of HLA class I functional divergence on HIV control:

Viard, Mathias ; O'hUigin, Colm ; Yuki, Yuko...
Science. 383 (2024) 6680 - p. 319-325 , 2024

Link: https://doi.org/10.1126/..

3

Clinical, molecular, and drug resistance epidemiology of HI..:

Bakri, Faris G. ; Mukattash, Heyam H. ; Esmeiran, Hiam...
International Journal of Infectious Diseases. 145 (2024) - p. 107079 , 2024

Link: https://doi.org/10.1016/..

4

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine ..:

Ober Shepherd, Brittany L ; Scott, Paul T ; Hutter, Jack N...
The Lancet Microbe. 5 (2024) 6 - p. e581-e593 , 2024

Link: https://doi.org/10.1016/..

5

Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strate..:

Julg, Boris ; Stephenson, Kathryn E. ; Tomaka, Frank...
npj Vaccines. 9 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Safety and immunogenicity of a purified inactivated Zika vi..:

Koren, Michael A ; Lin, Leyi ; Eckels, Kenneth H...
The Lancet Infectious Diseases. 23 (2023) 10 - p. 1175-1185 , 2023

Link: https://doi.org/10.1016/..

7

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant prot..:

Dayan, Gustavo H. ; Rouphael, Nadine ; Walsh, Stephen R....
eClinicalMedicine. 64 (2023) - p. 102168 , 2023

Link: https://doi.org/10.1016/..

8

Trivalent mosaic or consensus HIV immunogens prime humoral ..:

Cohen, Kristen W. ; Fiore-Gartland, Andrew ; Walsh, Stephen R....
Journal of Clinical Investigation. 133 (2023) 4 - p. , 2023

Link: https://doi.org/10.1172/..

9

Evolution of Antibody Responses in HIV-1 CRF01_AE Acute Inf..:

Kuriakose Gift, Syna ; Wieczorek, Lindsay ; Sanders-Buell, Eric...
Journal of Virology. 97 (2023) 2 - p. , 2023

Link: https://doi.org/10.1128/..

10

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombin..:

Dayan, Gustavo H ; Rouphael, Nadine ; Walsh, Stephen R...
The Lancet Respiratory Medicine. 11 (2023) 11 - p. 975-990 , 2023

Link: https://doi.org/10.1016/..

11

Safety and immunogenicity of a variant-adapted SARS-CoV-2 r..:

de Bruyn, Guy ; Wang, Joyce ; Purvis, Annie...
eClinicalMedicine. 62 (2023) - p. 102109 , 2023

Link: https://doi.org/10.1016/..

12

Viral vector delivered immunogen focuses HIV-1 antibody spe..:

Williams, LaTonya D. ; Shen, Xiaoying ; Sawant, Sheetal S....
PLOS Pathogens. 19 (2023) 5 - p. e1011359 , 2023

Link: https://doi.org/10.1371/..

13

Priming with Japanese encephalitis virus or yellow fever vi..:

Li, Yifan ; Merbah, Mélanie ; Wollen-Roberts, Suzanne...
eBioMedicine. 97 (2023) - p. 104815 , 2023

Link: https://doi.org/10.1016/..

14

SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ..:

Shrivastava, Shikha ; Carmen, Joshua M. ; Lu, Zhongyan...
npj Vaccines. 8 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

15

Tracking coreceptor switch of the transmitted/founder HIV-1..:

Marichannegowda, Manukumar Honnayakanahalli ; Zemil, Michelle ; Wieczorek, Lindsay...
eBioMedicine. 98 (2023) - p. 104867 , 2023

Link: https://doi.org/10.1016/..